These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 12561438)
41. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma. Bolat F; Gumurdulu D; Erkanli S; Kayaselcuk F; Zeren H; Ali Vardar M; Kuscu E Pathol Res Pract; 2008; 204(6):379-87. PubMed ID: 18343598 [TBL] [Abstract][Full Text] [Related]
42. Expression of MUC1 in primary and metastatic human epithelial ovarian cancer and its therapeutic significance. Wang L; Ma J; Liu F; Yu Q; Chu G; Perkins AC; Li Y Gynecol Oncol; 2007 Jun; 105(3):695-702. PubMed ID: 17368732 [TBL] [Abstract][Full Text] [Related]
43. Detection of serum transforming growth factor-alpha in patients of primary epithelial ovarian cancers by enzyme immunoassay. Chien CH; Huang CC; Lin YH; Shen J; Chow SN Gynecol Oncol; 1997 Sep; 66(3):405-10. PubMed ID: 9299253 [TBL] [Abstract][Full Text] [Related]
44. [Expression and significance of p-AKT, p-GSK3β and β-catenin in epithelial carcinoma of ovary]. Wei X; Lü QJ; Sun HX; Qi YF; Wang JO; Cao CC Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):86-90. PubMed ID: 22455883 [TBL] [Abstract][Full Text] [Related]
45. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma. Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319 [TBL] [Abstract][Full Text] [Related]
46. Diagnostic value of serum VEGF in women with ovarian tumors. Oehler MK; Caffier H Anticancer Res; 1999; 19(4A):2519-22. PubMed ID: 10470186 [TBL] [Abstract][Full Text] [Related]
47. DNA fragmentation factor (DFF45): expression and prognostic value in serous ovarian cancer. Brustmann H Pathol Res Pract; 2006; 202(10):713-20. PubMed ID: 16962250 [TBL] [Abstract][Full Text] [Related]
48. Survivin expression in ovarian cancer. Liguang Z; Peishu L; Hongluan M; Hong J; Rong W; Wachtel MS; Frezza EE Exp Oncol; 2007 Jun; 29(2):121-5. PubMed ID: 17704744 [TBL] [Abstract][Full Text] [Related]
49. Vascular endothelial growth factor (VEGF) concentration in sera and tumor effusions from patients with ovarian carcinoma. Harlozinska A; Sedlaczek P; Kulpa J; Grybos M; Wójcik E; Van Dalen A; Einarsson R Anticancer Res; 2004; 24(2C):1149-57. PubMed ID: 15154640 [TBL] [Abstract][Full Text] [Related]
50. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma. Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803 [TBL] [Abstract][Full Text] [Related]
51. Clinical significance of plasma D-dimer levels and serum VEGF levels in patients with hepatocellular carcinoma. Tseng CS; Lo HW; Chen PH; Chuang WL; Juan CC; Ker CG Hepatogastroenterology; 2004; 51(59):1454-8. PubMed ID: 15362775 [TBL] [Abstract][Full Text] [Related]
52. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor. Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105 [TBL] [Abstract][Full Text] [Related]
53. [Clinical significance of serum vascular endothelial growth factor and interleukin-6 in multiple myeloma]. Shen JK; Dong LH; Qi H; Zhang GS Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 30(1):68-71. PubMed ID: 15871192 [TBL] [Abstract][Full Text] [Related]
54. Vascular endothelial growth factor expression as a prognostic index in serous ovarian cystoadenocarcinomas: relationship with MIB1 immunostaining. Garzetti GG; Ciavattini A; Lucarini G; Pugnaloni A; De Nictolis M; Amati S; Romanini C; Biagini G Gynecol Oncol; 1999 Jun; 73(3):396-401. PubMed ID: 10366466 [TBL] [Abstract][Full Text] [Related]
56. Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer. Baron AT; Cora EM; Lafky JM; Boardman CH; Buenafe MC; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):103-13. PubMed ID: 12582019 [TBL] [Abstract][Full Text] [Related]
57. Pathogenetic pathways in ovarian endometrioid adenocarcinoma: a molecular study of 29 cases. Geyer JT; López-García MA; Sánchez-Estevez C; Sarrió D; Moreno-Bueno G; Franceschetti I; Palacios J; Oliva E Am J Surg Pathol; 2009 Aug; 33(8):1157-63. PubMed ID: 19542870 [TBL] [Abstract][Full Text] [Related]
58. Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients. Kassim SK; El-Salahy EM; Fayed ST; Helal SA; Helal T; Azzam Eel-D; Khalifa A Clin Biochem; 2004 May; 37(5):363-9. PubMed ID: 15087251 [TBL] [Abstract][Full Text] [Related]
59. VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer. Dalaveris E; Kerenidi T; Katsabeki-Katsafli A; Kiropoulos T; Tanou K; Gourgoulianis KI; Kostikas K Lung Cancer; 2009 May; 64(2):219-25. PubMed ID: 18845357 [TBL] [Abstract][Full Text] [Related]
60. [Expression of p21(WAF1) and its relationship with p53 and PCNA protein in epithelial ovarian cancer]. Yan XJ; Liang LZ; Li DC; Li JL; Zhang CQ; Yuan SH Ai Zheng; 2004 Jan; 23(1):74-80. PubMed ID: 14720380 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]